For the people leading communication and marketing efforts in the pharmaceutical industry, enhancing the performance of their brands means ensuring maximum return on investment, however long that return takes.
Achieving this takes more than simply carrying out clever marketing campaigns. Strategies need to be carefully considered to ensure content triggers the right emotions in target audiences to drive them to take the desired action.
How can marketers deliver this for their companies? Can behavioral economics, combined with AI (artificial intelligence) help?
Roy Rogers, Director at Research Partnership, an Inizio Advisory company, explores how understanding behavioral economics is essential to delivering more effective brand performance for pharmaceutical companies.
To find out more, click here.
A crucial topic gaining momentum is the urgent need to mitigate bias to improve patient outcomes…
Read moreThe 2024 ASCO® Annual Meeting held great significance for us, not only in showcasing our dedication to advancing cancer patient outcomes...
Read moreListening to patients and understanding their priorities can lead to better care plans that both extend and enhance patients' lives. Here’s how…
Read more